Health Care Providers’ Knowledge, Attitudes, and Practices Toward Medicinal Cannabis: The Case of Lebanon

Cannabis and Cannabinoid Research, Journal Year: 2024, Volume and Issue: unknown

Published: June 19, 2024

Background: In 2020, the Lebanese parliament legalized cannabis for medical and industrial use, sparking diverse reactions among health care professionals (HCP). Few studies have been conducted to reflect position of HCP on topic, no previous targeted all physicians with relevant specialties or had a large sample size. The current study aimed assess knowledge, attitude, practice community toward medicinal (MC). Methods: A cross-sectional was targeting from different backgrounds specialties. survey questionnaire disseminated through scientific societies in Order Physicians other professional bodies. An online shared oncologists, rheumatologists, psychiatrists, neurologists, pharmacists, psychotherapists across geographic regions. It covered questions about sociodemographic details, related MC. Descriptive bivariate analyses were performed. total 202 responded survey, yielding response rate 34%. Results: Eighteen percent participants described their level knowledge indications MC as good. Twenty-five respondents are willing prescribe, 30% "may consider" it. Among those majority may consider treat chronic pain, palliative care, post-traumatic stress disorder, epilepsy, anxiety. Respondents' side effects is follows: driving difficulties (82%), addiction (69%), drug interactions (65%), weight gain (43%). Willingness prescribe varies by specialty, clinical experience MC, gender. expressed concerns potential harm using indicated that legalization would negatively impact society. Sixty-nine reported not receiving any formal education agreed need expand its effects. should be dispensed based prescription physician special training recognized importance establishing national registry patients undergoing treatment, well necessity guidelines approval. Conclusion: data indicate attitudes prescribing vary gender, experience. Implementation effective educational strategies Lebanon enhance promote proper use crucial.

Language: Английский

---

The attitudes, knowledge and confidence of healthcare professionals about cannabis-based products

Journal of Cannabis Research, Journal Year: 2024, Volume and Issue: 6(1)

Published: July 24, 2024

Abstract Background Use of cannabis-based products is becoming more frequent, and it important that healthcare professionals are informed confident about them when making evidence-based decisions their use. This study aimed to gain an international perspective on the attitudes, knowledge, confidence products. Methods An online questionnaire regarding these was completed by 1580 (neurologists, psychiatrists, general practitioners, pharmacists nurses) from 16 countries across Asia, Europe, Oceania, South America, Middle East. Results Respondents expressed a high level interest in (median score 9 out 10) reported they felt knowledgeable 6 7). They providing patients with information products, returning median scores 5 7 for legality regulations, benefits risks, respectively. Despite this, sought further areas including legality, neurobiology, scientific evidence. Finally, 59% (n = 930) respondents considered robust clinical trial evidence as most factor ensure patient safety context Few nominally significant differences emerged between different specialities or regions. Conclusion In conclusion, this large survey attitudes held towards revealed demand information. Limitations include potential sample bias limited external validity.

Language: Английский

---

An exploration of medical professionals’ attitudes, perceived knowledge and concerns around medical cannabis in the United Kingdom

Drug Science Policy and Law, Journal Year: 2024, Volume and Issue: 10

Published: Jan. 1, 2024

Background In the UK, there are over 40,000 specialist clinicians who eligible to prescribe cannabis-based medical products (CBMPs); however, only approximately 100 actively do so (0.25%). Since legalization of cannabis in UK 2018, has been a limited number prescriptions issued by National Health Service (NHS). Availability through private healthcare is rising, with current estimates suggesting that 25,000–30,000 patients accessing though clinics. Objective The objectives this study were (1) assess attitudes, perceived knowledge and concerns around among medical/health care professionals (HCPs) (2) examine differences between had previously undertaken training on those not. Methods Using quantitative cross-sectional survey design, questionnaire was presented participants explore their personal professional perspectives towards cannabis. Questions addressed HCPs’ knowledge, confidence about prescribing, alongside experiences attitudes toward legalization. Results A total 72 HCPs completed survey, which 55.6% received trained reported statistically significant higher cannabis, greater prescribing increased recognition its value as medicine compared non-trained colleagues ( p < 0.05 for all comparisons). Notably, individuals significantly less concerned use lacks sufficient evidence efficacy X 2 = 8.74, 0.003). Barriers prescription cost most endorsed both HCP groups. Conclusions found undergoing associated hesitancy CBMPs medicinal value.

Language: Английский

---

Patient–provider interactions about cannabis for therapeutic purposes vary as a function of provider type: A pilot study

American Journal on Addictions, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 24, 2024

Abstract Background and Objectives Limited evidence guides the efficacy safety of cannabis for therapeutic purposes (CTP). Healthcare providers lack requisite knowledge to advise support patients. This study aimed describe compare several aspects initial CTP interactions across different provider types. Methods Adult consumers ( N = 507) from United States completed an anonymous online survey about their interaction with healthcare provider. Providers were categorized into four groups (Mental Health [MH], Family Medicine [FM], Medical Clinics [MC], Other Specialty [OS]). Analyses compared (e.g., risk mitigation, recommendations, satisfaction/confidence) groups. Results Less than half sample reported discussion risks (44.0%) or follow‐ups at subsequent visits (46.7%). Recommendations (where obtain, consumption method, dose, frequency, authorization) uncommon (9.7%–25.2%). While MH group highest rates mitigation behaviors, regression models adjusted sociodemographic characteristics largely nonsignificant. For MC was more likely report receiving all recommendations p < .05). Younger age greater cannabis‐related problems increased likelihood recommendations. Discussion Conclusions focused on but generally lacked comprehensive that could potentially promote safe use. Data perspectives need guidelines develop training practices. Scientific Significance first time, this explored experiences a variety providers.

Language: Английский

---

Primary Care Providers’ Communication About Medical Cannabis With Older Adults: A Cross-Sectional Survey

Journal of Primary Care & Community Health, Journal Year: 2024, Volume and Issue: 15

Published: Jan. 1, 2024

Healthcare providers often hesitate to discuss medical cannabis (MC) due limited understanding, risks and benefits, misinformation. This reluctance is notable with older adult patients, despite MC's potential benefits. study investigates whether primary care (PCPs) routinely inquire about MC when treating adults the frequency of such inquiries.

Language: Английский

---